Regeneron Pharmaceuticals (REGN34.SA) Q4 2022 Earnings

3NovConfirmed
Q1 2022
Q2 2022
Q3 2022
Q4 2022
43.92
67.14
90.35
113.57

Details

Expected EPS
48.898444
Actual EPS
56.979986
Surprise EPS
8.08
Surprise Percent
+16.53%

Description

Regeneron Pharmaceuticals (REGN34.SA) has reported earnings of 56.979986 per share for Q4 2022.

0 Comments

Share your thoughts